You have 9 free searches left this month | for more free features.

Condition

Dry Eye Syndromes (1)

Pancreatic Cancer (1)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Redwood Pharma AB (1)

SciClone Pharmaceuticals (1)

Collaborator

Cross Research S.A. (1)

Intervention

rp101 (2)

gemcitabine (1000 mg/m2) (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

rp101

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Dry Eye Syndromes Trial in Austria, Germany, Hungary (RP101)

Completed

Dry Eye Syndromes

RP101

Vienna, Austria
+7 more

Dec 19, 2019

Pancreatic Cancer Trial in Worldwide (RP101, Gemcitabine (1000 mg/m2))

Terminated

Pancreatic Cancer

RP101
Gemcitabine (1000 mg/m2)

Tucson, Arizona
+54 more

Jun 6, 2011